Trials / Completed
CompletedNCT04481750
Study of Oral Edaravone in Healthy Adult Males
Phase I Study of Oral Edaravone in Healthy Adult Males (Single- and Multiple-dose Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetics safety, and tolerability of single and multiple doses of edaravone solution and suspension in healthy adult males
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-1186 | Solution or suspension |
| DRUG | MT-1186-matching placebo | Solution or suspension |
Timeline
- Start date
- 2018-03-20
- Primary completion
- 2018-08-03
- Completion
- 2018-08-03
- First posted
- 2020-07-22
- Last updated
- 2026-01-07
- Results posted
- 2024-08-02
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04481750. Inclusion in this directory is not an endorsement.